MSD Korea's Cholesterol Absorption Inhibitor Now Available

Six months after obtaining a market approval by the Korea Food and Drug Administration (KFDA), MSD Korea officially announced that Ezetrol, a cholesterol absorption inhibitor, is now available in the domestic market.

According to the company, Ezetrol (active ingredient: ezetimibe) is regarded as the first treatment from a class of lipid-lowering compounds that selectively inhibit the intes...